All stories

1 outlets · filed 10 November 2026

FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss

This story is from the archive. It was covered between 10 November 2026 and 10 November 2026, and nothing below has been updated since. See what is happening now.

The risk appears small and data is mixed, but FDA wants patients to be aware.

What the coverage shows

Both outlets focus on the FDA warning about GLP-1 drugs and the rare vision-loss risk, and both present it as a caution rather than a major confirmed harm. Ars Technica explicitly says the risk appears small and the data are mixed, while 60 Minutes frames the drugs as now carrying a warning about a rare but potentially dangerous side effect. Only 60 Minutes adds the detail that a doctor joins CBS News to discuss it.

Written by Crossfiled from the 1 headlines and extracts below, not from the articles themselves. It describes how the outlets framed this, not what happened. Open any headline for a summary of that article.

Ars Technica

How it broke

1outlets
0videos
1articles

More on Health

Every Health story, across every outlet